310 related articles for article (PubMed ID: 36647777)
1. Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies.
Yao C; Wu S; Kong J; Sun Y; Bai Y; Zhu R; Li Z; Sun W; Zheng L
Cancer Biol Med; 2023 Jan; 20(1):25-43. PubMed ID: 36647777
[TBL] [Abstract][Full Text] [Related]
2. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.
Zheng N; Zhang S; Wu W; Zhang N; Wang J
Pharmacol Res; 2021 Apr; 166():105507. PubMed ID: 33610718
[TBL] [Abstract][Full Text] [Related]
3. Supramolecular Polymer-Nanomedicine Hydrogel Loaded with Tumor Associated Macrophage-Reprogramming polyTLR7/8a Nanoregulator for Enhanced Anti-Angiogenesis Therapy of Orthotopic Hepatocellular Carcinoma.
Liu X; Huangfu Y; Wang J; Kong P; Tian W; Liu P; Fang C; Li S; Nie Y; Feng Z; Huang P; Shi S; Zhang C; Dong A; Wang W
Adv Sci (Weinh); 2023 Aug; 10(22):e2300637. PubMed ID: 37229748
[TBL] [Abstract][Full Text] [Related]
4. Positive feedback loop between cancer stem cells and angiogenesis in hepatocellular carcinoma.
Yao H; Liu N; Lin MC; Zheng J
Cancer Lett; 2016 Sep; 379(2):213-9. PubMed ID: 27108065
[TBL] [Abstract][Full Text] [Related]
5. Vascular changes in hepatocellular carcinoma.
Yang ZF; Poon RT
Anat Rec (Hoboken); 2008 Jun; 291(6):721-34. PubMed ID: 18484619
[TBL] [Abstract][Full Text] [Related]
6. Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy.
Kasprzak A; Adamek A
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563158
[TBL] [Abstract][Full Text] [Related]
7. Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma.
Yang C; Qin S
Cancer Med; 2018 Sep; 7(9):4570-4583. PubMed ID: 30109780
[TBL] [Abstract][Full Text] [Related]
8. Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma.
Zhang L; Xu J; Zhou S; Yao F; Zhang R; You W; Dai J; Yu K; Zhang Y; Baheti T; Pu L; Xu J; Qian X; Zhang C; Xia Y; Dai X; Li Q; Wang X
J Hepatol; 2024 Jan; 80(1):82-98. PubMed ID: 37838036
[TBL] [Abstract][Full Text] [Related]
9. Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma.
Tanaka S; Arii S
Int J Clin Oncol; 2006 Apr; 11(2):82-9. PubMed ID: 16622743
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives.
Sun HC; Tang ZY
J Cancer Res Clin Oncol; 2004 Jun; 130(6):307-19. PubMed ID: 15034787
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A.
Wu SX; Ye SS; Hong YX; Chen Y; Wang B; Lin XJ; Lin X
J Virol; 2022 Feb; 96(4):e0197521. PubMed ID: 34910612
[TBL] [Abstract][Full Text] [Related]
12. Targeting angiogenic genes as a therapeutic approach for hepatocellular carcinoma.
Wong CH; Wong CS; Chan SL
Curr Gene Ther; 2015; 15(2):97-108. PubMed ID: 25537771
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma.
Pang R; Poon RT
Cancer Lett; 2006 Oct; 242(2):151-67. PubMed ID: 16564617
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions.
Hilmi M; Neuzillet C; Calderaro J; Lafdil F; Pawlotsky JM; Rousseau B
J Immunother Cancer; 2019 Nov; 7(1):333. PubMed ID: 31783782
[TBL] [Abstract][Full Text] [Related]
15. Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells.
Wei Y; Yang Q; Zhang Y; Zhao T; Liu X; Zhong J; Ma J; Chen Y; Zhao C; Li J
Oncotarget; 2017 Feb; 8(9):15230-15241. PubMed ID: 28122355
[TBL] [Abstract][Full Text] [Related]
16. The Role of Angiogenesis in Hepatocellular Carcinoma.
Morse MA; Sun W; Kim R; He AR; Abada PB; Mynderse M; Finn RS
Clin Cancer Res; 2019 Feb; 25(3):912-920. PubMed ID: 30274981
[TBL] [Abstract][Full Text] [Related]
17. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic therapies for advanced hepatocellular carcinoma.
Sampat KR; O'Neil B
Oncologist; 2013; 18(4):430-8. PubMed ID: 23576483
[TBL] [Abstract][Full Text] [Related]
19. Molecular targeted therapies in hepatocellular carcinoma.
Tanaka S; Arii S
Semin Oncol; 2012 Aug; 39(4):486-92. PubMed ID: 22846865
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in hepatocellular carcinoma: a potential target for chemoprevention and therapy.
Bishayee A; Darvesh AS
Curr Cancer Drug Targets; 2012 Nov; 12(9):1095-118. PubMed ID: 22873221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
